The DOI matches its Crossref record; 140 of the 140 references it cites were found in a registry or an index.
Cannabinoid-Induced Immune Suppression and Modulation of Antigen-Presenting Cells
Abstract
The study of marijuana cannabinoid biology has led to many important discoveries in neuroscience and immunology. These studies have uncovered a new physiological system, the endocannabinoid system, which operates in the regulation of not only brain function but also the regulation of the immune system. Studies examining the effect of cannabinoid-based drugs on immunity have shown that many cellular and cytokine mechanisms are suppressed by these agents leading to the hypothesis that these drugs may be of value in the management of chronic inflammatory diseases. In this report, we review current information on cannabinoid ligand and receptor biology, mechanisms involved in immune suppression by cannabinoids with emphasis on antigen-presenting cells, and preclinical and clinical models analyzing the therapeutic potential of cannabinoid-based drugs.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Cannabinoids also inhibit the cell-specific proliferation of B and T cells (Cabral and Griffin-Thomas, 2009;Klein and Cabral, 2006).”
From The endogenous cannabinoid system: a budding source of targets for treating inflammatory and neuropathic pain (2018) · cites this paper as Klein and Cabral, 2006
Citations
Cites
International Union of Pharmacology: Approaches to the Nomenclature of Voltage-Gated Ion Channels
Catterall, W. A., Chandy, K. G., Clapham, D. E., Gutman, G. A., Hofmann, F., Harmar, A. J., Abernethy, D. R., & Spedding, M. (2003) · Pharmacological Reviews · doi:10.1124/pr.55.4.5 · Cited by 7,126
Isolation and Structure of a Brain Constituent That Binds to the Cannabinoid Receptor
Devane, W. A., Hanuš, L., Breuer, A., Pertwee, R. G., Stevenson, L. A., Griffin, G., Gibson, D., Mandelbaum, A., Etinger, A., & Mechoulam, R. (1992) · Science · doi:10.1126/science.1470919 · Cited by 5,633
Molecular characterization of a peripheral receptor for cannabinoids
Munro, S., Thomas, K. L., & Abu-Shaar, M. (1993) · Nature · doi:10.1038/365061a0 · Cited by 5,092
Structure of a cannabinoid receptor and functional expression of the cloned cDNA
Matsuda, L. A., Lolait, S. J., Brownstein, M. J., Young, A. C., & Bonner, T. I. (1990) · Nature · doi:10.1038/346561a0 · Cited by 5,011
Mechoulam, R., Ben-Shabat, S., Hanus, L., Ligumsky, M., Kaminski, N. E., Schatz, A. R., Gopher, A., Almog, S., Martin, B. R., Compton, D. R., et al. (1995) · Biochemical Pharmacology · doi:10.1016/0006-2952(95)00109-d · Cited by 2,913
International Union of Pharmacology. XXVII. Classification of Cannabinoid Receptors
Howlett, A. C., Barth, F., Bonner, T. I., Cabral, G., Casellas, P., Devane, W. A., Felder, C. C., Herkenham, M., Mackie, K., Martin, B. R., et al. (2002) · Pharmacological Reviews · doi:10.1124/pr.54.2.161 · Cited by 2,819
Self-citationDetermination and characterization of a cannabinoid receptor in rat brain
Devane, W. A., Dysarz, F. A., Johnson, M. R., Melvin, L. S., & Howlett, A. C. (1988) · Molecular Pharmacology · doi:10.1016/s0026-895x(25)09876-1 · Cited by 2,443 · cited 2×
“Receptors A number of pharmacological studies with highaffinity ligands strongly supported the existence of cannabinoid receptors (Devane et al. 1988), and the gene for the first of these (CB1) was eventually cloned from brain in 1990 (Matsuda et al. 1990) with a second receptor (CB2) cloned a few…”
BackgroundIsolation, Structure, and Partial Synthesis of an Active Constituent of Hashish
Gaoni, Y., & Mechoulam, R. (1964) · Journal of the American Chemical Society · doi:10.1021/ja01062a046 · Cited by 2,389
Vanilloid receptors on sensory nerves mediate the vasodilator action of anandamide
Zygmunt, P. M., Petersson, J., Andersson, D. A., Chuang, H.-H., Sørgård, M., Di Marzo, V., Julius, D., & Högestätt, E. D. (1999) · Nature · doi:10.1038/22761 · Cited by 2,142
Galiègue, S., Mary, S., Marchand, J., Dussossoy, D., Carrière, D., Carayon, P., Bouaboula, M., Shire, D. J., Fur, G. L., & Casellas, P. (1995) · European Journal of Biochemistry · doi:10.1111/j.1432-1033.1995.tb20780.x · Cited by 1,776
Cited by
Sorted by citations
Cannabinoids and the gut: New developments and emerging concepts
Izzo, A. A., & Sharkey, K. A. (2010) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2009.12.005 · Cited by 434
Donvito, G., Nass, S. R., Wilkerson, J. L., Curry, Z. A., Schurman, L. D., Kinsey, S. G., & Lichtman, A. H. (2018) · Neuropsychopharmacology · doi:10.1038/npp.2017.204 · Cited by 301
Effects of Marijuana Smoking on the Lung
Tashkin, D. P. (2013) · Annals of the American Thoracic Society · doi:10.1513/annalsats.201212-127fr · Cited by 298
Probiotics, Prebiotics, and Phytogenic Substances for Optimizing Gut Health in Poultry
Shehata, A. A., Yalçın, S., Latorre, J. D., Basiouni, S., Attia, Y. A., El‐Wahab, A. A., Visscher, C., El-Seedi, H. R., Huber, C., Hafez, H. M., et al. (2022) · Microorganisms · doi:10.3390/microorganisms10020395 · Cited by 329
Kozela, E., Pietr, M., Juknat, A., Rimmerman, N., Levy, R., & Vogel, Z. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.069294 · Cited by 322
Cannabinoid-induced apoptosis in immune cells as a pathway to immunosuppression
Rieder, S. A., Chauhan, A., Singh, U., Nagarkatti, M., & Nagarkatti, P. S. (2009) · Immunobiology · doi:10.1016/j.imbio.2009.04.001 · Cited by 264
Baron, E. P. (2018) · Headache The Journal of Head and Face Pain · doi:10.1111/head.13345 · Cited by 268
O'Sullivan, S., & Kendall, D. (2010) · Immunobiology · doi:10.1016/j.imbio.2009.09.007 · Cited by 249
Cannabinoids and the immune system: An overview
Tănăsescu, R., & Constantinescu, C. S. (2010) · Immunobiology · doi:10.1016/j.imbio.2009.12.005 · Cited by 246
Chanda, P. K., Gao, Y., Mark, L., Btesh, J., Strassle, B. W., Lu, P., Piesla, M. J., Zhang, M.-Y., Bingham, B., Uveges, A. J., et al. (2010) · Molecular Pharmacology · doi:10.1124/mol.110.068304 · Cited by 236
Serum and gene expression profile of cytokines in first-episode psychosis
Di Nicola, M., Cattaneo, A., Hepgul, N., Di Forti, M., Aitchison, K. J., Janiri, L., Murray, R. M., Dazzan, P., Pariante, C. M., & Mondelli, V. (2013) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2012.06.010 · Cited by 217
Baron, E. P. (2015) · Headache The Journal of Head and Face Pain · doi:10.1111/head.12570 · Cited by 219
Clinical applications of hallucinogens: a review
Garcia-Romeu, A., Kersgaard, B., & Addy, P. H. (2016) · Experimental and Clinical Psychopharmacology · doi:10.1037/pha0000084 · Cited by 201
Cannabis, the pregnant woman and her child: weeding out the myths
Jaques, S. C., Kingsbury, A. M., Henshcke, P., Chomchai, C., Clews, S., Falconer, J., Abdellatif, M., Feller, J. M., & Oei, J. L. (2014) · Journal of Perinatology · doi:10.1038/jp.2013.180 · Cited by 199
Hillard, C. J., Weinlander, K. M., & Stuhr, K. L. (2011) · Neuroscience · doi:10.1016/j.neuroscience.2011.11.020 · Cited by 190
Goods and Bads of the Endocannabinoid System as a Therapeutic Target: Lessons Learned after 30 Years
Maccarrone, M., Di Marzo, V., Gertsch, J., Grether, U., Howlett, A. C., Hua, T., Makriyannis, A., Piomelli, D., Ueda, N., & van der Stelt, M. (2023) · Pharmacological Reviews · doi:10.1124/pharmrev.122.000600 · Cited by 183
Baron, E. P., Lucas, P., Eades, J., & Hogue, O. (2018) · The Journal of Headache and Pain · doi:10.1186/s10194-018-0862-2 · Cited by 188
Zhang, M., Martin, B. R., Adler, M. W., Razdan, R. K., Jallo, J., & Tuma, R. F. (2007) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1038/sj.jcbfm.9600447 · Cited by 165
Cannabis Impacts Tumor Response Rate to Nivolumab in Patients with Advanced Malignancies
Taha, T., Meiri, D., Talhamy, S., Wollner, M., Peer, A., & Bar‐Sela, G. (2019) · The Oncologist · doi:10.1634/theoncologist.2018-0383 · Cited by 157
Cannabinoids and autoimmune diseases: A systematic review
Katchan, V., David, P., & Shoenfeld, Y. (2016) · Autoimmunity Reviews · doi:10.1016/j.autrev.2016.02.008 · Cited by 147
Cannabinoids, Endocannabinoids, and Related Analogs in Inflammation
BURSTEIN, S. H., & Zurier, R. B. (2009) · The AAPS Journal · doi:10.1208/s12248-009-9084-5 · Cited by 139
Kopustinskienė, D. M., Masteiková, R., Lažauskas, R., & Bernatonienė, J. (2022) · Antioxidants · doi:10.3390/antiox11040660 · Cited by 155
Drugs of Abuse, Immune Modulation, and AIDS
Cabral, G. A. (2006) · Journal of Neuroimmune Pharmacology · doi:10.1007/s11481-006-9023-5 · Cited by 132
Self-citationZhang, M., Adler, M. W., Abood, M. E., Ganea, D., Jallo, J., & Tuma, R. F. (2009) · Microvascular Research · doi:10.1016/j.mvr.2009.03.005 · Cited by 124
Neuroprotective agents: Cannabinoids
Sánchez, A., & García-Merino, A. (2011) · Clinical Immunology · doi:10.1016/j.clim.2011.02.010 · Cited by 125
The Cannabinoid Receptor 2 Is Critical for the Host Response to Sepsis
Tschöp, J., Kasten, K. R., Nogueiras, R., Goetzman, H. S., Cave, C. M., England, L. G., Dattilo, J. R., Lentsch, A. B., Tschöp, M. H., & Caldwell, C. C. (2009) · The Journal of Immunology · doi:10.4049/jimmunol.0900203 · Cited by 119
Juknat, A., Pietr, M., Kozela, E., Rimmerman, N., Levy, R., Gao, F., Coppola, G., Geschwind, D. H., & Vogel, Z. (2013) · PLoS ONE · doi:10.1371/journal.pone.0061462 · Cited by 121
Zhang, M., Martin, B. R., Adler, M. W., Razdan, R. K., Ganea, D., & Tuma, R. F. (2008) · Neuroscience · doi:10.1016/j.neuroscience.2008.01.022 · Cited by 116
Reece, A. S., Norman, A. F., & Hulse, G. K. (2016) · BMJ Open · doi:10.1136/bmjopen-2016-011891 · Cited by 112
Siniscalco, D., Sapone, A., Giordano, C., Cirillo, A., de Magistris, L., Rossi, F., Fasano, A., Bradstreet, J. J., Maione, S., & Antonucci, N. (2013) · Journal of Autism and Developmental Disorders · doi:10.1007/s10803-013-1824-9 · Cited by 108
Modulation of Cannabinoid Receptor Activation as a Neuroprotective Strategy for EAE and Stroke
Zhang, M., Martin, B. R., Adler, M. W., Razdan, R. J., Kong, W., Ganea, D., & Tuma, R. F. (2009) · Journal of Neuroimmune Pharmacology · doi:10.1007/s11481-009-9148-4 · Cited by 101
Spice/K2 drugs – more than innocent substitutes for marijuana
Zawilska, J. B., & Wojcieszak, J. (2013) · The International Journal of Neuropsychopharmacology · doi:10.1017/s1461145713001247 · Cited by 98
The antimicrobial effect behind Cannabis sativa
Schofs, L., Sparo, M. D., & Bruni, S. F. S. (2021) · Pharmacology Research & Perspectives · doi:10.1002/prp2.761 · Cited by 102
Opioid Receptors and Signaling on Cells from the Immune System
Bidlack, J. M., Khimich, M., Parkhill, A. L., Sumagin, S., Sun, B., & Tipton, C. M. (2006) · Journal of Neuroimmune Pharmacology · doi:10.1007/s11481-006-9026-2 · Cited by 93
Cannabis smoking and respiratory health: Consideration of the literature
Gates, P., Jaffé, A., & Copeland, J. (2014) · Respirology · doi:10.1111/resp.12298 · Cited by 90
Juknat, A., Pietr, M., Kozela, E., Rimmerman, N., Levy, R., Coppola, G., Geschwind, D. H., & Vogel, Z. (2011) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2011.01461.x · Cited by 90
Rajasekaran, M., Brents, L. K., Franks, L. N., Moran, J. H., & Prather, P. L. (2013) · Toxicology and Applied Pharmacology · doi:10.1016/j.taap.2013.03.012 · Cited by 90
Finn, D. P. (2009) · Immunobiology · doi:10.1016/j.imbio.2009.05.011 · Cited by 91
Immunoregulatory Role of Cannabinoids during Infectious Disease
Hernández‐Cervantes, R., Méndez‐Díaz, M., Prospero-Garcia, O. E., & Morales‐Montor, J. (2017) · NeuroImmunoModulation · doi:10.1159/000481824 · Cited by 86
Cannabinoid Receptor Type 2: A Possible Target in SARS-CoV-2 (CoV-19) Infection?
Rossi, F., Tortora, C., Argenziano, M., Paola, A. D., & Punzo, F. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21113809 · Cited by 83
Cannabinoids as Key Regulators of Inflammasome Signaling: A Current Perspective
Suryavanshi, S. V., Kovalchuk, I., & Kovalchuk, O. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2020.613613 · Cited by 87
Elliott, M. B., Tuma, R. F., Amenta, P. S., Barbe, M. F., & Jallo, J. (2011) · Journal of Neurotrauma · doi:10.1089/neu.2010.1672 · Cited by 77
Britch, S. C., Goodman, A. G., Wiley, J. L., Pondelick, A. M., & Craft, R. M. (2020) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.119.263319 · Cited by 79
The endocannabinoid system modulates stress, emotionality, and inflammation
Crowe, M. S., Nass, S. R., Gabella, K. M., & Kinsey, S. G. (2014) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2014.06.007 · Cited by 72
Lu, T., Newton, C. A., Perkins, I., Friedman, H. P., & Klein, T. (2006) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.106.108381 · Cited by 69
Self-citationEffects of cannabinoids and their receptors on viral infections
Tahamtan, A., Tavakoli‐Yaraki, M., Rygiel, T. P., Mokhtari‐Azad, T., & Salimi, V. (2015) · Journal of Medical Virology · doi:10.1002/jmv.24292 · Cited by 66
Cannabis for the treatment of Crohn's disease
Kafil, T. S., Nguyen, T. M., MacDonald, J. K., & Chande, N. (2018) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd012853.pub2 · Cited by 66
Functions of the CB1 and CB2 Receptors in Neuroprotection at the Level of the Blood–Brain Barrier
Vendel, E., & de Lange, E. C. M. (2014) · NeuroMolecular Medicine · doi:10.1007/s12017-014-8314-x · Cited by 67
Agudelo, M., Newton, C. A., Widen, R. H., Sherwood, T. A., Nong, L., Friedman, H. P., & Klein, T. (2007) · Journal of Neuroimmune Pharmacology · doi:10.1007/s11481-007-9088-9 · Cited by 62
Self-citationJuknat, A., Gao, F., Coppola, G., Vogel, Z., & Kozela, E. (2019) · PLoS ONE · doi:10.1371/journal.pone.0212039 · Cited by 67
Newton, C. A., Chou, P.-J., Perkins, I., & Klein, T. (2008) · Journal of Neuroimmune Pharmacology · doi:10.1007/s11481-008-9126-2 · Cited by 62
Self-citationToxic effects of prenatal exposure to alcohol, tobacco and other drugs
Scott-Goodwin, A. C., Puerto, M., & Moreno, I. (2016) · Reproductive Toxicology · doi:10.1016/j.reprotox.2016.03.043 · Cited by 62
Sainsbury, B., Bloxham, J., Pour, M. H., Padilla, M., & Enciso, R. (2021) · Journal of Dental Anesthesia and Pain Medicine · doi:10.17245/jdapm.2021.21.6.479 · Cited by 61
Robinson, R. H., Meissler, J. J., Deckman, J. M., Gaughan, J. P., Adler, M. W., & Eisenstein, T. K. (2013) · Journal of Neuroimmune Pharmacology · doi:10.1007/s11481-013-9485-1 · Cited by 60
Cannabinoids and Viral Infections
Reiss, C. S. (2010) · Pharmaceuticals · doi:10.3390/ph3061873 · Cited by 59
Xu, T., Gao, X., Wu, Z., Selinger, D. W., & Zhou, Z. (2020) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2020.04.01.017624 · Cited by 57
Buchweitz, J. P., Karmaus, P. W. F., Williams, K. J., Harkema, J. R., & Kaminski, N. E. (2007) · Journal of Leukocyte Biology · doi:10.1189/jlb.0907618 · Cited by 55
Cannabis for the treatment of Crohn's disease
Kafil, T. S., Nguyen, T. M., MacDonald, J. K., & Chande, N. (2017) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd012853 · Cited by 53
Alshaarawy, O., & Anthony, J. C. (2014) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2014.11.017 · Cited by 51
Therapeutic Potential of Cannabinoid-Based Drugs
Klein, T., & Newton, C. A. (2007) · Advances in experimental medicine and biology · doi:10.1007/978-0-387-72005-0_43 · Cited by 49
Self-citationCannabis for the treatment of ulcerative colitis
Kafil, T. S., Nguyen, T. M., MacDonald, J. K., & Chande, N. (2018) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd012954.pub2 · Cited by 47
Cannabinoids as therapeutics for PTSD
Sbarski, B., & Akirav, I. (2020) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2020.107551 · Cited by 47
Castaneda, J. T., Harui, A., Kiertscher, S. M., Roth, J. D., & Roth, M. D. (2013) · Journal of Neuroimmune Pharmacology · doi:10.1007/s11481-012-9430-8 · Cited by 47
Romano, B., Pagano, E., Orlando, P., Capasso, R., Cascio, M. G., Pertwee, R. G., Marzo, V. D., Izzo, A. A., & Borrelli, F. (2016) · Pharmacological Research · doi:10.1016/j.phrs.2016.07.045 · Cited by 46
Autism Spectrum Disorder and Medical Cannabis: Review and Clinical Experience
Mostafavi, M., & Gaitanis, J. N. (2020) · Seminars in Pediatric Neurology · doi:10.1016/j.spen.2020.100833 · Cited by 56
Konieczka, P., Szkopek, D., Kinsner, M., Fotschki, B., Juśkiewicz, J., & Banach, J. (2020) · Veterinary Research · doi:10.1186/s13567-020-00863-0 · Cited by 45
The Immune Endocannabinoid System of the Tumor Microenvironment
Kienzl, M., Kargl, J., & Schicho, R. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21238929 · Cited by 47
Reece, A. S. (2007) · Substance Abuse Treatment Prevention and Policy · doi:10.1186/1747-597x-2-35 · Cited by 43
The Endocannabinoid System in Pediatric Inflammatory and Immune Diseases
Argenziano, M., Tortora, C., Bellini, G., Paola, A. D., Punzo, F., & Rossi, F. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20235875 · Cited by 43
Determinants of pulse wave velocity trajectories from youth to young adulthood
Liang, X., Su, S., Hao, G., Snieder, H., Treiber, F. A., Kapuku, G. K., & Wang, X. (2018) · Journal of Hypertension · doi:10.1097/hjh.0000000000001933 · Cited by 42
Braun, A., Engel, T., Aguilar‐Pimentel, J. A., Zimmer, A., Jakob, T., Behrendt, H., & Mempel, M. (2010) · Immunobiology · doi:10.1016/j.imbio.2010.09.004 · Cited by 41
Kristanc, L., & Kreft, S. (2016) · Food and Chemical Toxicology · doi:10.1016/j.fct.2016.03.014 · Cited by 37
Potential pharmacological approaches for the treatment of HIV-1 associated neurocognitive disorders
Omeragic, A., Kayode, O., Hoque, M. T., & Bendayan, R. (2020) · Fluids and Barriers of the CNS · doi:10.1186/s12987-020-00204-5 · Cited by 38
Karoly, H. C., Mueller, R. L., Bidwell, L. C., & Hutchison, K. E. (2019) · Alcoholism Clinical and Experimental Research · doi:10.1111/acer.14256 · Cited by 37
Cannabidiol affects the expression of genes involved in zinc homeostasis in BV-2 microglial cells
Juknat, A., Rimmerman, N., Levy, R., Vogel, Z., & Kozela, E. (2011) · Neurochemistry International · doi:10.1016/j.neuint.2011.12.002 · Cited by 35
Anti-inflammatory effects of CBD in human microglial cell line infected with HIV-1
Yndart, A., Kolishetti, N., Vashist, A., Madepalli, L., Llaguno, L., & Nair, M. G. (2023) · Scientific Reports · doi:10.1038/s41598-023-32927-4 · Cited by 34
CB2 Receptor Agonists Protect Human Dopaminergic Neurons against Damage from HIV-1 gp120
Hu, S., Sheng, W. S., & Rock, R. B. (2013) · PLoS ONE · doi:10.1371/journal.pone.0077577 · Cited by 34
Zogopoulos, P., Vasileiou, I., Patsouris, E., & Theocharis, S. E. (2013) · Journal of Applied Toxicology · doi:10.1002/jat.2828 · Cited by 34
Endocannabinoid system and its modulation of brain, gut, joint and skin inflammation
Osafo, N., Yeboah, K. O., & Antwi, A. O. (2021) · Molecular Biology Reports · doi:10.1007/s11033-021-06366-1 · Cited by 35
Roth, M. D., Castaneda, J. T., & Kiertscher, S. M. (2015) · Journal of Neuroimmune Pharmacology · doi:10.1007/s11481-015-9587-z · Cited by 31
Strisciuglio, C., Bellini, G., Miele, E., Martinelli, M., Cenni, S., Tortora, C., Tolone, C., del Giudice, E. M., & Rossi, F. (2016) · Journal of Clinical Gastroenterology · doi:10.1097/mcg.0000000000000755 · Cited by 29
Regulation of Cell Surface CB2 Receptor during Human B Cell Activation and Differentiation
Castaneda, J. T., Harui, A., & Roth, M. D. (2017) · Journal of Neuroimmune Pharmacology · doi:10.1007/s11481-017-9744-7 · Cited by 27
Marcellin, F., Lions, C., Rosenthal, É., Roux, P., Sogni, P., Wittkop, L., Protopopescu, C., Spire, B., Salmon, D., Dabis, F., et al. (2016) · Drug and Alcohol Review · doi:10.1111/dar.12398 · Cited by 26
Williams, J., Klein, T., Goldberger, B. A., Sleasman, J. W., Mackman, N., & Goodenow, M. M. (2015) · Journal of Inflammation · doi:10.1186/s12950-015-0084-1 · Cited by 25
Self-citationAnandamide prior to sensitization increases cell-mediated immunity in mice
Ribeiro, A., Ferraz-de-Paula, V., Pinheiro, M. L., Sakai, M., Costa‐Pinto, F. A., & Palermo‐Neto, J. (2010) · International Immunopharmacology · doi:10.1016/j.intimp.2009.12.017 · Cited by 25
Sexton, M. (2020) · The Journal of Alternative and Complementary Medicine · doi:10.1089/acm.2020.0144 · Cited by 24
Abdel‐Salam, O. M. E., Nada, S. A., Salem, N. A., El-Shamarka, M. E.-S., & Omara, E. A. A. (2013) · Comparative Clinical Pathology · doi:10.1007/s00580-013-1745-1 · Cited by 24
Gibson, C. L., Nia, A. B., Spriggs, S. A., DeFrancisco, D., Swift, A., Perkel, C., Zhong, X., Mazumdar, M., Fernandez, N., Patel, M., et al. (2020) · Psychiatry Research · doi:10.1016/j.psychres.2020.113380 · Cited by 22
Tan, Q., Chen, Q., Feng, Z., Shi, X., Tang, J., Tao, Y., Jiang, B., Tan, L., Feng, H., Zhu, G., et al. (2016) · Brain Research · doi:10.1016/j.brainres.2016.10.016 · Cited by 22
Cannabinoids and the Cannabinoid Receptors: An Overview
Lu, D., & Potter, D. E. (2017) · Elsevier eBooks · doi:10.1016/b978-0-12-800756-3.00068-5 · Cited by 23
Wasik, A. M., Christensson, B., & Sander, B. (2011) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2011.10.004 · Cited by 21
Zielińska, A., Eder, P., Karczewski, J., Szalata, M., Hryhorowicz, S., Wielgus, K., Szalata, M., Dobrowolska, A., Atanasov, A. G., Słomski, R., et al. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1147991 · Cited by 22
Moretti, S., Castelli, M., Franchi, S., Raggi, M. A., Mercolini, L., Protti, M., Somaini, L., Panerai, A. E., & Sacerdote, P. (2014) · Journal of Leukocyte Biology · doi:10.1189/jlb.3hi0713-406rr · Cited by 22
Sexton, M., Silvestroni, A., Möller, T., & Stella, N. (2012) · Inflammopharmacology · doi:10.1007/s10787-012-0133-9 · Cited by 20
Cannabinoids and Endocannabinoid System Changes in Intestinal Inflammation and Colorectal Cancer
Cherkasova, V., Kovalchuk, O., & Kovalchuk, I. (2021) · Cancers · doi:10.3390/cancers13174353 · Cited by 20
Exposure to morphine affects the expression of endocannabinoid receptors and immune functions
Zhang, Q., Zhang, M., & Cao, Y. (2012) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2012.04.003 · Cited by 19
Parameters of the Endocannabinoid System as Novel Biomarkers in Sepsis and Septic Shock
Lafreniere, J. D., & Lehmann, C. (2017) · Metabolites · doi:10.3390/metabo7040055 · Cited by 19
Riera, R., Pacheco, R. L., Bagattini, Â. M., & Martimbianco, A. L. C. (2021) · Phytotherapy Research · doi:10.1002/ptr.7263 · Cited by 19
Jin, L., Pan, L., Guo, Y., Zheng, Y., Nie, Z., & Zhu, R. (2014) · Acta Neurobiologiae Experimentalis · doi:10.55782/ane-2014-1994 · Cited by 19
Clinical implications of addiction related immunosuppression
Reece, A. S. (2008) · Journal of Infection · doi:10.1016/j.jinf.2008.03.003 · Cited by 19
Metadata
- Authors
- Klein, T. W., & Cabral, G. A.
- Affiliations
- University of South Florida (US)
- Virginia Commonwealth University (US)
- Corresponding author
- Klein, Thomas W.
- ORCID
- Klein, Thomas W.
- Venue
- Journal of Neuroimmune Pharmacology
- Published
- 2006-02-22
- Volume
- 1
- Issue
- 1
- Pages
- 50-64
- ISSN
- 1557-1890 (ISSN-L)
- 1557-1904
- OpenAlex
- W2061663043
- Cited by
- 172
- References
- 139
- Citations by year
- 2026: 4 · 2025: 6 · 2024: 8 · 2023: 6 · 2022: 4 · 2021: 12 · 2020: 16 · 2019: 9 · 2018: 6 · 2017: 11 · 2016: 13 · 2015: 6 · 2014: 9 · 2013: 13 · 2012: 6
- FWCI
- 0.94
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Journal of Neuroimmune Pharmacology (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Institute on Drug Abuse (DA15608, DA05832, R01DA003646, DA03646, R01DA015608)
- Topics
- Health Sciences › Medicine › Pharmacology (medical) › Cannabis and Cannabinoid Research
- Life Sciences › Immunology and Microbiology › Immunology › Immunotoxicology and immune responses
- Health Sciences › Medicine › Pharmacology (medical) › Inflammatory mediators and NSAID effects
- Keywords
- cannabinoids, endocannabinoid system, immunosuppression, antigen-presenting cells, cannabinoid receptors, cytokines, chronic inflammatory diseases, immunomodulation
- MeSH terms
- Animals, Antigen-Presenting Cells, Cannabinoids, Cannabis, Humans, Inflammation, Receptors, Cannabinoid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review